Medicare Coverage for Peripheral Artery Disease (PAD)

Peripheral artery disease affects an estimated 8 to 12 million Americans, with the majority of cases occurring in people over 65. The condition — caused by plaque buildup that narrows the arteries supplying blood to the legs, feet, and sometimes arms — ranges from mildly limiting leg pain during walking to the threat of amputation when blood flow becomes critically low.

Because Medicare peripheral artery disease coverage spans diagnosis, physical rehabilitation, catheter-based procedures, open surgery, wound care, prosthetics, and multiple prescription drug classes, understanding exactly how each piece works helps patients plan their care and avoid financial surprises. This guide walks through every stage of PAD treatment under Original Medicare, explains where Medicare Advantage may expand benefits, and identifies the out-of-pocket costs you should plan for.

What Peripheral Artery Disease Is and Why It Affects So Many Medicare Beneficiaries

Peripheral artery disease (also called peripheral arterial disease or PAD) develops when fatty deposits accumulate on arterial walls outside the heart and brain — most often in the arteries of the pelvis, thighs, calves, and feet. The narrowing reduces or blocks blood flow to the lower extremities.

PAD shares the same underlying disease process as coronary artery disease and shares the same risk factors: smoking, type 2 diabetes, hypertension, high cholesterol, obesity, and age. Because all of these risk factors become more prevalent after 60, and because decades of cumulative arterial damage must accumulate before symptoms appear, PAD is overwhelmingly a disease of Medicare-age adults. Men are affected at higher rates, but postmenopausal women close the gap significantly.

The three clinical presentations that drive Medicare utilization:

1. Intermittent claudication — cramping, aching, or fatigue in the calf, thigh, or buttock triggered by walking and relieved by rest. The hallmark symptom of moderate PAD.
2. Rest pain — severe burning or aching pain in the foot or toes while lying down, relieved by hanging the foot off the bed. Signals advanced PAD requiring urgent evaluation.
3. Critical limb-threatening ischemia (CLTI) — persistent ischemic rest pain, non-healing wounds (ulcers), or gangrene. Without revascularization, limb loss is likely within weeks.

Each stage involves different Medicare-covered services, and the financial exposure escalates significantly as the disease progresses.

Step 1 — Diagnosing PAD: What Medicare Covers

Medicare Part B covers the diagnostic tests used to evaluate suspected PAD as outpatient physician services. After you meet the annual Part B deductible ($283 in 2026), you pay 20% coinsurance.

Ankle-Brachial Index (ABI) Testing

The ankle-brachial index is the primary screening and diagnostic test for PAD. A technician measures blood pressure at the ankle and arm simultaneously; a ratio below 0.90 is diagnostic for PAD. The test is non-invasive, takes about 30 minutes, and is typically performed in a vascular lab or cardiologist’s office.

Medicare Part B covers ABI testing when a physician documents clinical suspicion of PAD. Patient cost: typically $25–$50 after 20% coinsurance once the deductible is met.

Duplex Ultrasound of the Peripheral Vessels

Duplex ultrasound combines conventional ultrasound with Doppler flow measurement to visualize blood flow through individual arteries and identify the location and severity of narrowing. It’s the standard next step when the ABI is abnormal or when more precise anatomic detail is needed.

Medicare Part B covers duplex ultrasound as an outpatient diagnostic service. Patient cost: typically $60–$120 after 20% coinsurance.

CT Angiography (CTA) and MR Angiography (MRA)

When endovascular or surgical treatment is being planned, vascular surgeons need a detailed roadmap of the arterial anatomy. CTA and MRA provide three-dimensional images that show exactly where disease is located, how severe the narrowing is, and what vessels remain open below the blockage (the “runoff” that determines whether bypass surgery is technically feasible).

Medicare Part B covers CTA and MRA when ordered for medically necessary indications. Patient cost: typically $150–$400 after 20% coinsurance, depending on whether contrast is used.

Diagnostic Angiography

Conventional catheter angiography — where dye is injected directly through a catheter into the arterial system — provides the most detailed imaging but is invasive. Medicare covers diagnostic angiography under Part B (outpatient) or Part A (inpatient), depending on where it’s performed.

Step 2 — Supervised Exercise Therapy: A Medicare-Specific Benefit

One of the most underutilized and cost-effective treatments for intermittent claudication is supervised exercise therapy (SET). In 2017, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination (NCD 20.35) explicitly covering SET for Medicare beneficiaries with symptomatic PAD.

What Medicare’s SET benefit covers:

• Up to 36 one-hour sessions over a 12-week period (approximately three sessions per week)
• If medically necessary, the treating physician can order an additional 36 sessions (72 total) in the same 12-month period
• Sessions must be supervised directly by qualified auxiliary personnel with physician oversight
• Setting: hospital outpatient department or physician office

Who qualifies for SET under Medicare:

• Documented diagnosis of PAD
• Symptomatic intermittent claudication (leg pain limiting walking)
• A physician referral and documented treatment plan

What patients pay: SET sessions are billed as outpatient services under Part B. After the $283 deductible (2026), you pay 20% of the Medicare-approved amount per session. Each session typically costs Medicare $80–$120, so patient cost per session runs $16–$24, or roughly $600–$870 for the full 36-session course. With a Medigap Plan G, your share drops to near zero.

Why SET matters: Randomized trials show supervised exercise therapy improves walking distance and quality of life comparably to angioplasty for many patients with claudication — at a fraction of the cost and with none of the procedural risks. Yet fewer than 5% of eligible Medicare beneficiaries ever enroll. The coverage exists; the obstacle is usually physician referral and finding a certified SET program.

Step 3 — Endovascular Procedures: Angioplasty, Stenting, and Atherectomy

When PAD progresses beyond what medications and exercise can manage — or when critical limb ischemia makes urgent intervention necessary — the first-line revascularization approach is usually an endovascular procedure: a catheter-based technique that reaches the blocked artery from the inside.

Procedures covered by Medicare:

• Balloon angioplasty: A catheter with an inflatable balloon compresses plaque against the arterial wall to widen the channel.
• Peripheral stenting: A metal mesh tube (stent) is deployed to hold the vessel open after angioplasty. Drug-eluting stents (coated with medication to resist re-narrowing) are now standard in many locations.
• Atherectomy: A cutting or laser device physically removes or ablates plaque. Multiple devices (directional, rotational, orbital, laser) are used depending on the lesion type.

How Medicare covers endovascular PAD procedures:

Coverage depends on where the procedure is performed:

Endovascular procedures are increasingly performed in the outpatient setting. An outpatient femoral-popliteal angioplasty with stenting typically carries a Medicare-approved amount of $8,000–$15,000; your 20% share is $1,600–$3,000. Complex multilevel procedures or those requiring longer recovery may require inpatient admission, triggering Part A cost-sharing instead.

Planned vs. Emergency Procedures

When a procedure is planned electively to treat claudication, outpatient is the norm. When a patient presents with critical limb ischemia, threatened amputation, or acute limb ischemia from sudden clot, hospitalization for urgent or emergent intervention is common — and Part A covers the inpatient stay.

Step 4 — Bypass Surgery: Open Surgical Revascularization

For complex multilevel disease — particularly when the popliteal artery and tibial vessels below the knee are severely diseased — open bypass surgery may offer better long-term patency than endovascular options. A vascular surgeon uses a section of the patient’s own saphenous vein (preferred) or a synthetic graft to route blood around the blocked segment.

Medicare Part A coverage for bypass surgery:

Bypass surgery is performed as an inpatient procedure. Medicare Part A covers:

• The surgical procedure itself
• The inpatient hospital stay
• Post-surgical nursing care and monitoring
• Physical and occupational therapy during the inpatient stay
• Medically necessary home health care after discharge if the patient is homebound

Patient cost for bypass surgery under Part A:

• Days 1–60: $1,736 deductible per benefit period, then $0/day coinsurance
• Days 61–90: $434/day coinsurance (2026)
• Beyond 90 days: lifetime reserve days apply at $868/day (2026)

A typical femoral-popliteal bypass hospitalization lasts 4–7 days. At 5 days, patient cost is simply the $1,736 benefit-period deductible — assuming no prior hospitalization in the same benefit period.

Post-surgical care: Medicare Part A also covers skilled nursing facility (SNF) care when the patient needs ongoing skilled rehabilitation after discharge — provided the hospitalization was at least three consecutive inpatient days and the SNF admission occurs within 30 days. SNF care is covered in full for days 1–20, then at $217/day for days 21–100 (2026).

Step 5 — Critical Limb-Threatening Ischemia and Limb Salvage

Critical limb-threatening ischemia (CLTI) represents the end stage of PAD: chronic ischemic rest pain, non-healing wounds, and gangrene driven by severely inadequate blood flow. Without revascularization, major amputation is typically necessary within months to save the patient’s life.

Medicare coverage in CLTI:

• Wound care: Outpatient wound care centers bill under Part B. Complex wound care for ischemic ulcers may require debridement, advanced wound dressings, and specialized wound therapy — all covered by Part B with the standard 20% coinsurance.
• Hyperbaric oxygen therapy (HBO): Medicare Part B covers HBO as an outpatient service for select non-healing wounds, including diabetic foot wounds with inadequate blood flow. Coverage requires a treating physician’s order and documentation that conventional wound care has failed.
• Revascularization procedures: Whether endovascular or surgical, these are covered as described above — urgently for CLTI, with hospital admission usually required.
• Amputation: When limb salvage fails, Medicare Part A covers the inpatient amputation procedure, post-surgical care, and initial prosthetic evaluation. Part B covers outpatient prosthetic fitting and devices.

Medicare Coverage of Prosthetic Limbs

Following a major amputation (below-knee, above-knee, or transfemoral), Medicare Part B covers prosthetic limbs as durable medical equipment (DME). Coverage rules:

• The prescribing physician must document that the prosthesis is medically necessary for the patient’s ambulatory potential
• Medicare approves an “initial” prosthetic device and periodic replacements as the residual limb matures
• Advanced microprocessor-controlled prosthetic knees and feet are covered when the patient’s functional level (K level) justifies them — Medicare uses K2/K3/K4 classifications that assess ambulation ability

Patient cost for prosthetics: 20% coinsurance under Part B after the deductible. A basic below-knee prosthetic approved by Medicare typically costs $5,000–$12,000; Medicare covers 80%, leaving a $1,000–$2,400 patient share.

Medications for PAD: What Medicare Part D Covers

Most PAD patients require multiple medications to slow disease progression, reduce cardiovascular risk, and manage symptoms. Medicare Part D (prescription drug coverage) covers these drugs, though cost varies by plan formulary and tier placement.

Medications commonly prescribed for PAD:

Cost and tier placement: Generic statins, ACE inhibitors, clopidogrel, and aspirin are universally available on Part D formularies at Tier 1–2 (typically $0–$15/month). Rivaroxaban and cilostazol are brand or specialty agents; tier placement varies widely, and prior authorization may be required.

PAD’s Connection to Other Medicare-Covered Conditions

PAD is rarely an isolated diagnosis. Its risk factors — smoking, diabetes, hypertension, high cholesterol — are also the drivers of coronary artery disease, stroke, chronic kidney disease, and diabetic foot complications. Medicare covers each of these related conditions, and PAD care often runs in parallel with:

• Medicare and heart disease — shared risk factors mean PAD patients often receive concurrent cardiac imaging and management. Part B covers echocardiograms, stress tests, and cardiologist consultations.
• Medicare and diabetes — diabetic PAD is more aggressive than non-diabetic PAD. Diabetes management — glucose monitoring supplies, insulin, A1c testing — is covered by Parts B and D and directly slows PAD progression.
• Medicare and stroke/TIA — patients with PAD have two to four times the risk of stroke compared to the general population. Carotid artery imaging, neurology consultations, and antiplatelet therapy are often co-managed.
• Medicare and chronic kidney disease — CKD and PAD frequently coexist (shared endothelial disease mechanisms, nephrotoxic contrast dye concerns that change imaging choices) and require coordinated care.
• Healthcare costs in retirement — PAD treatment, especially for CLTI requiring multiple revascularization attempts, can generate tens of thousands of dollars in annual Medicare costs. Planning for this exposure is an essential part of retirement healthcare budgeting.

Reducing Out-of-Pocket Costs for PAD Treatment

PAD care can generate substantial out-of-pocket exposure, especially for patients who progress to complex revascularization or multiple hospitalizations. Several programs reduce this burden:

Medigap (Medicare Supplement) Insurance

A Medigap plan dramatically reduces PAD-related out-of-pocket costs. Plan G — the most popular among new enrollees — covers:

• The $1,736 Part A deductible per benefit period
• All Part A hospital coinsurance (days 61–90 at $434/day, lifetime reserve at $868/day)
• 365 extra inpatient hospital days beyond Medicare’s limit
• The 20% Part B coinsurance on outpatient procedures, office visits, and supervised exercise sessions
• Part B excess charges

Note that Plan G does not cover the Part B deductible ($283 in 2026) — that’s the one cost you pay out of pocket regardless. Plan F covered the Part B deductible but is no longer available to beneficiaries who became Medicare-eligible after January 1, 2020.

For a PAD patient who might have multiple outpatient procedures and hospitalizations in a year, Plan G transforms unpredictable five-figure exposure into a fixed, predictable premium.

Medicare Advantage for PAD Patients

Medicare Advantage plans vary significantly in how they cover PAD. Some plans offer:

• Lower specialist copays for vascular surgery and interventional cardiology
• Annual out-of-pocket maximums ($3,000–$8,000 range) that cap exposure in years with intensive revascularization treatment
• Extra benefits (gym memberships, meal delivery after surgery) that support PAD recovery

However, Medicare Advantage requires using network providers, which can be limiting if you need a specialized vascular surgery center. Compare carefully before enrolling if PAD treatment is anticipated.

Medicare Savings Programs

If your income is limited, Medicare Savings Programs can eliminate most PAD-related costs. The Qualified Medicare Beneficiary (QMB) program pays Part A and Part B premiums, deductibles, and coinsurance — meaning diagnostic tests, supervised exercise sessions, and even hospitalization costs are largely eliminated.

Income limits for 2026: QMB eligibility is generally set at or near 100% of the Federal Poverty Level (approximately $15,060/year for individuals), with asset limits that vary by state.

Planning Your PAD Care Under Medicare

Peripheral artery disease follows a predictable escalation — from risk factors and early symptoms through claudication, rest pain, and eventually critical ischemia for patients who do not adequately control the underlying risk factors. At every stage, Medicare provides substantial coverage. The key planning points:

1. Don’t skip the ABI test. If you have diabetes, a history of smoking, or known heart disease, ask your physician for an ABI test. Early detection allows supervised exercise and medication to slow progression.

2. Use the supervised exercise benefit. Very few eligible patients enroll in SET, yet it rivals angioplasty for claudication outcomes. It’s covered by Medicare with modest cost-sharing and avoids procedural risks.

3. Get a Medigap plan before complex PAD treatment begins. Multiple hospitalizations or endovascular procedures in a single year can stack Part A deductibles and Part B coinsurance into five-figure exposure. Medigap converts that to a predictable premium.

4. Coordinate with a vascular surgeon early. If your cardiologist or primary care physician has identified severe PAD, a vascular surgery consultation — covered by Part B — maps out the treatment options before the situation becomes an emergency.

5. Control the risk factors. Stopping smoking, controlling blood sugar, and taking guideline-directed medications (statins, antiplatelet agents, ACE inhibitors) are the most powerful tools for slowing PAD progression and reducing the need for costly procedures.

Frequently Asked Questions About Medicare and PAD

Does Medicare cover vascular surgery for PAD? Yes. Both endovascular procedures (angioplasty, stenting, atherectomy) and open bypass surgery are covered by Medicare. Outpatient procedures are covered under Part B with 20% coinsurance; inpatient surgery is covered under Part A with the $1,736 benefit-period deductible.

Is supervised exercise therapy for PAD covered by Medicare? Yes. Since 2017, CMS has covered up to 36 supervised exercise sessions (extensible to 72 with a physician order) specifically for Medicare beneficiaries with symptomatic PAD. You pay 20% coinsurance under Part B, which typically amounts to $16–$24 per session.

Does Medicare cover prosthetics after PAD-related amputation? Yes. Part B covers prosthetic limbs as durable medical equipment when the treating physician documents medical necessity. Medicare covers 80% of the Medicare-approved amount; you pay 20% plus any Part B deductible.

What is the out-of-pocket cost for PAD angioplasty under Medicare? For an outpatient endovascular procedure, you pay the $283 Part B deductible plus 20% of the Medicare-approved amount. For a typical procedure, that’s $1,600–$3,000. For an inpatient procedure, the Part A deductible of $1,736 per benefit period applies with no daily coinsurance for days 1–60.

Does Medicare Advantage cover PAD the same way as Original Medicare? Coverage is generally equivalent or better under Medicare Advantage (by law, MA plans must cover all Original Medicare-covered services). The differences are cost-sharing structure (copays vs. coinsurance), provider network restrictions, and prior authorization requirements for elective procedures. Some MA plans require authorization before elective angioplasty or bypass surgery; confirm with your plan before scheduling.